Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Cancer Prev Res (Phila). 2011 Jan;4(1):161–171. doi: 10.1158/1940-6207.CAPR-10-0021

Figure 1. β-catenin and cyclin D1 expression in human sporadic adenomas.

Figure 1

A, representative examples of β-catenin immunohistochemical analyses in untreated (a,b) and NSAID-treated (c, d) adenomas at 200× (a,c) and 400× (b,d) magnification, performed as described under Materials and methods. B, representative examples of cyclin D1 immunohistochemical analysis in untreated (a,b) and NSAID treated (c,d) adenomas at 200× (a,c) and 400× (b,d) magnification, performed as described under Materials and Methods. C, representative examples of β-catenin (a,b) and cyclin D1 (c,d) co-localized immunostaining in serial sections of an untreated adenoma at 100× (a,c) and 400× (b,d) magnification.

HHS Vulnerability Disclosure